We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights Johnson & Johnson, Caterpillar, Qualcomm, Fossil and Jones Soda
Read MoreHide Full Article
For Immediate Release
Chicago, IL – January 9, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Johnson & Johnson (JNJ - Free Report) , Caterpillar Inc. (CAT - Free Report) , Qualcomm Inc. (QCOM - Free Report) , Fossil Group, Inc. (FOSL - Free Report) and Jones Soda Co. (JSDA - Free Report) .
Here are highlights from Thursday’s Analyst Blog:
Top Analyst Reports for Johnson & Johnson, Caterpillar and Qualcomm
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson, Caterpillar Inc. and Qualcomm Inc., as well as two micro-cap stocks Fossil Group, Inc. and Jones Soda Co.. The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.
These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
The daily 'Ahead of Wall Street' article is a must-read for all investors who would like to be ready for that day's trading action. The article comes out before the market opens, attempting to make sense of that morning's economic releases and how they will affect that day's market action. You can read this article for free on our home page and can actually sign up there to get an email notification as this article comes out each morning.
Johnson & Johnson's shares have outperformed the Zacks Large Cap Pharmaceuticals industry over the past six months (+35.3% vs. +23.9%). The company's Innovative Medicine unit is showing a growth trend, driven by key products like Darzalex, Tremfya and Erleada and continued uptake of new launches, like Spravato, Carvykti, and Tecvayli, despite Stelara LOE.
The MedTech segment showed improved operational growth in the past two quarters. J&J expects sales growth in both segments to be higher in 2026. J&J has also rapidly advanced its pipeline in 2025 that will help drive growth through the back half of the decade.
However, the Stelara patent cliff, the impact of Part D redesign and MedTech China issues were significant headwinds in 2025. The uncertainty around the unresolved legal issues lingers. Estimates are stable ahead of Q4 results. J&J has a positive record of earnings surprises in recent quarters.
Shares of Caterpillar have outperformed the Zacks Manufacturing - Construction and Mining industry over the past six months (+52.3% vs. +51%). The company reported year-over-year growth in its third-quarter revenues after six quarters of declines. This improvement was attributed to volume growth in all of its segments.
However, earnings declined in the quarter due to the impact of tariffs. This will continue through 2025 with the company expecting a $1.6-$1.75 billion impact for the year. The record high backlog of $39.9 billion should support its top line. Going forward, the Construction Industries segment will gain from increased construction activities in the United States and globally.
Resource Industries will be supported by commodity demand. The Energy & Transportation segment will gain on strong demand across all applications. Caterpillar's focus on aftermarket parts and service-related revenues (which generate high margins) will aid growth.
Qualcomm's shares have gained +13.8% over the past six months against the Zacks Electronics - Semiconductors industry's gain of +27.6%. The company is witnessing healthy traction in EDGE networking that helps to transform connectivity in cars, business enterprises, homes, smart factories, next-generation PCs, wearables and tablets.
Qualcomm is foraying deeper into the realm of AI capabilities within the laptop and desktop business with the launch of the Snapdragon X chip for mid-range AI desktops and laptops. Qualcomm Snapdragon mobile platforms and Digital Chassis platform for automotive connectivity are also gaining traction.
However, a shift in the share among OEMs at the premium tier has reduced Qualcomm's near-term opportunity to sell integrated chipsets. Stiff competition in the mobile phone chipset market is also likely to hurt profits in the future. The strained bilateral Sino-US trade relationship clouds its revenue-generating potential.
Shares of Fossil have outperformed the Zacks Retail - Apparel and Shoes industry over the past six months (+110.4% vs. +16.4%). This microcap company with a market capitalization of $199.99 million is executing a strategic turnaround marked by a stronger capital structure and cost discipline. The November 2025 debt exchange extended maturities to 2029 and added a $150 million revolver through 2030, easing liquidity strain and reflecting lender confidence.
SG&A cuts of $100 million for FY25, including layoffs and store closures, support leaner operations and improve leverage. A renewed focus on core products supports margin stability and brand equity. Jewelry and leather categories, though currently weak, offer long-term upside via digital growth in Asia-Pacific. Execution under new leadership is yielding early gains in cost structure and geographic profitability.
However, Fossil faces ongoing losses, shrinking revenue and strained liquidity. Tariff exposure and weak brand relevance remain headwinds. Despite a +114% stock rally in the past six months, valuation remains low at 0.27X EV/sales.
Jones Soda's shares have outperformed the Zacks Beverages - Soft drinks industry over the past six months (+31.7% vs. -0.1%). This microcap company with market capitalization of $28.49 million is having upside hinges on expanding distribution and culturally resonant partnerships that can drive sustained velocity across the retail, club and D2C channels. Limited-edition collaborations and ongoing innovation support premium positioning, repeat purchases and stronger retailer relationships.
The modern soda lineup benefits from consumer shifts toward functional and lower-sugar options, helping secure incremental shelf space. Improved access to non-dilutive capital strengthens execution capacity for inventory planning and channel expansion.
Key risks include regulatory uncertainty tied to hemp-derived products, which could force reformulation or exit and introduce compliance costs. Balance sheet pressure may constrain strategic flexibility, while core demand remains sensitive to promotions and seasonal ordering rather than a steady baseline pull.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Shutterstock
The Zacks Analyst Blog Highlights Johnson & Johnson, Caterpillar, Qualcomm, Fossil and Jones Soda
For Immediate Release
Chicago, IL – January 9, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Johnson & Johnson (JNJ - Free Report) , Caterpillar Inc. (CAT - Free Report) , Qualcomm Inc. (QCOM - Free Report) , Fossil Group, Inc. (FOSL - Free Report) and Jones Soda Co. (JSDA - Free Report) .
Here are highlights from Thursday’s Analyst Blog:
Top Analyst Reports for Johnson & Johnson, Caterpillar and Qualcomm
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson, Caterpillar Inc. and Qualcomm Inc., as well as two micro-cap stocks Fossil Group, Inc. and Jones Soda Co.. The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.
These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today's research reports here >>>
Ahead of Wall Street
The daily 'Ahead of Wall Street' article is a must-read for all investors who would like to be ready for that day's trading action. The article comes out before the market opens, attempting to make sense of that morning's economic releases and how they will affect that day's market action. You can read this article for free on our home page and can actually sign up there to get an email notification as this article comes out each morning.
You can read today's AWS here >>> Pre-markets Soft on Excellent Economic Data
Today's Featured Research Reports
Johnson & Johnson's shares have outperformed the Zacks Large Cap Pharmaceuticals industry over the past six months (+35.3% vs. +23.9%). The company's Innovative Medicine unit is showing a growth trend, driven by key products like Darzalex, Tremfya and Erleada and continued uptake of new launches, like Spravato, Carvykti, and Tecvayli, despite Stelara LOE.
The MedTech segment showed improved operational growth in the past two quarters. J&J expects sales growth in both segments to be higher in 2026. J&J has also rapidly advanced its pipeline in 2025 that will help drive growth through the back half of the decade.
However, the Stelara patent cliff, the impact of Part D redesign and MedTech China issues were significant headwinds in 2025. The uncertainty around the unresolved legal issues lingers. Estimates are stable ahead of Q4 results. J&J has a positive record of earnings surprises in recent quarters.
(You can read the full research report on Johnson & Johnson here >>>)
Shares of Caterpillar have outperformed the Zacks Manufacturing - Construction and Mining industry over the past six months (+52.3% vs. +51%). The company reported year-over-year growth in its third-quarter revenues after six quarters of declines. This improvement was attributed to volume growth in all of its segments.
However, earnings declined in the quarter due to the impact of tariffs. This will continue through 2025 with the company expecting a $1.6-$1.75 billion impact for the year. The record high backlog of $39.9 billion should support its top line. Going forward, the Construction Industries segment will gain from increased construction activities in the United States and globally.
Resource Industries will be supported by commodity demand. The Energy & Transportation segment will gain on strong demand across all applications. Caterpillar's focus on aftermarket parts and service-related revenues (which generate high margins) will aid growth.
(You can read the full research report on Caterpillar here >>>)
Qualcomm's shares have gained +13.8% over the past six months against the Zacks Electronics - Semiconductors industry's gain of +27.6%. The company is witnessing healthy traction in EDGE networking that helps to transform connectivity in cars, business enterprises, homes, smart factories, next-generation PCs, wearables and tablets.
Qualcomm is foraying deeper into the realm of AI capabilities within the laptop and desktop business with the launch of the Snapdragon X chip for mid-range AI desktops and laptops. Qualcomm Snapdragon mobile platforms and Digital Chassis platform for automotive connectivity are also gaining traction.
However, a shift in the share among OEMs at the premium tier has reduced Qualcomm's near-term opportunity to sell integrated chipsets. Stiff competition in the mobile phone chipset market is also likely to hurt profits in the future. The strained bilateral Sino-US trade relationship clouds its revenue-generating potential.
(You can read the full research report on Qualcomm here >>>)
Shares of Fossil have outperformed the Zacks Retail - Apparel and Shoes industry over the past six months (+110.4% vs. +16.4%). This microcap company with a market capitalization of $199.99 million is executing a strategic turnaround marked by a stronger capital structure and cost discipline. The November 2025 debt exchange extended maturities to 2029 and added a $150 million revolver through 2030, easing liquidity strain and reflecting lender confidence.
SG&A cuts of $100 million for FY25, including layoffs and store closures, support leaner operations and improve leverage. A renewed focus on core products supports margin stability and brand equity. Jewelry and leather categories, though currently weak, offer long-term upside via digital growth in Asia-Pacific. Execution under new leadership is yielding early gains in cost structure and geographic profitability.
However, Fossil faces ongoing losses, shrinking revenue and strained liquidity. Tariff exposure and weak brand relevance remain headwinds. Despite a +114% stock rally in the past six months, valuation remains low at 0.27X EV/sales.
(You can read the full research report on Fossil here >>>)
Jones Soda's shares have outperformed the Zacks Beverages - Soft drinks industry over the past six months (+31.7% vs. -0.1%). This microcap company with market capitalization of $28.49 million is having upside hinges on expanding distribution and culturally resonant partnerships that can drive sustained velocity across the retail, club and D2C channels. Limited-edition collaborations and ongoing innovation support premium positioning, repeat purchases and stronger retailer relationships.
The modern soda lineup benefits from consumer shifts toward functional and lower-sugar options, helping secure incremental shelf space. Improved access to non-dilutive capital strengthens execution capacity for inventory planning and channel expansion.
Key risks include regulatory uncertainty tied to hemp-derived products, which could force reformulation or exit and introduce compliance costs. Balance sheet pressure may constrain strategic flexibility, while core demand remains sensitive to promotions and seasonal ordering rather than a steady baseline pull.
(You can read the full research report on Jones Soda here >>>)
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.